↓ Skip to main content

Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog

Overview of attention for article published in BMC Veterinary Research, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
5 X users
facebook
3 Facebook pages

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
64 Mendeley
Title
Hepatopathy following consumption of a commercially available blue-green algae dietary supplement in a dog
Published in
BMC Veterinary Research, June 2015
DOI 10.1186/s12917-015-0453-2
Pubmed ID
Authors

Adrienne C. Bautista, Caroline E. Moore, Yanping Lin, Martha G. Cline, Noemi Benitah, Birgit Puschner

Abstract

Dietary supplement use in both human and animals to augment overall health continues to increase and represents a potential health risk due to the lack of safety regulations imposed on the manufacturers. Because there are no requirements for demonstrating safety and efficacy prior to marketing, dietary supplements may contain potentially toxic contaminants such as hepatotoxic microcystins produced by several species of blue-green algae. An 11-year-old female spayed 8.95 kg Pug dog was initially presented for poor appetite, lethargy polyuria, polydipsia, and an inability to get comfortable. Markedly increased liver enzyme activities were detected with no corresponding abnormalities evident on abdominal ultrasound. A few days later the liver enzyme activities were persistently increased and the dog was coagulopathic indicating substantial liver dysfunction. The dog was hospitalized for further care consisting of oral S-adenosylmethionine, silybin, vitamin K, and ursodeoxycholic acid, as well as intravenous ampicillin sodium/sulbactam sodium, dolasetron, N-acetylcysteine, metoclopramide, and intravenous fluids. Improvement of the hepatopathy and the dog's clinical status was noted over the next three days. Assessment of the dog's diet revealed the use of a commercially available blue-green algae dietary supplement for three-and-a-half weeks prior to hospitalization. The supplement was submitted for toxicology testing and revealed the presence of hepatotoxic microcystins (MCs), MC-LR and MC-LA. Use of the supplement was discontinued and follow-up evaluation over the next few weeks revealed a complete resolution of the hepatopathy. To the authors' knowledge, this is the first case report of microcystin intoxication in a dog after using a commercially available blue-green algae dietary supplement. Veterinarians should recognize the potential harm that these supplements may cause and know that with intervention, recovery is possible. In addition, more prudent oversight of dietary supplement use is recommended for our companion animals to prevent adverse events/intoxications.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 16%
Student > Master 10 16%
Other 6 9%
Lecturer > Senior Lecturer 3 5%
Student > Postgraduate 3 5%
Other 13 20%
Unknown 19 30%
Readers by discipline Count As %
Veterinary Science and Veterinary Medicine 12 19%
Agricultural and Biological Sciences 8 13%
Medicine and Dentistry 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Nursing and Health Professions 2 3%
Other 14 22%
Unknown 19 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 March 2022.
All research outputs
#2,462,726
of 23,452,723 outputs
Outputs from BMC Veterinary Research
#159
of 3,101 outputs
Outputs of similar age
#32,302
of 266,118 outputs
Outputs of similar age from BMC Veterinary Research
#3
of 64 outputs
Altmetric has tracked 23,452,723 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,101 research outputs from this source. They receive a mean Attention Score of 4.0. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 266,118 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.